Accuracy of Self-Report and Pill-Count Measures of Adherence in the FEM-PrEP Clinical Trial: Implications for Future HIV-Prevention Trials.
about
Divergent adherence estimates with pharmacokinetic and behavioural measures in the MTN-003 (VOICE) studyFacilitators of adherence to the study pill in the FEM-PrEP clinical trialSelf-monitoring of lower leg skin temperature: accuracy of self-reported data and adherence to a cooling protocol for the prevention of venous leg ulcers.Dose response for starting and stopping HIV preexposure prophylaxis for men who have sex with men.An intravaginal ring for real-time evaluation of adherence to therapyDose Frequency Ranging Pharmacokinetic Study of Tenofovir-Emtricitabine After Directly Observed Dosing in Healthy Volunteers to Establish Adherence Benchmarks (HPTN 066)Current concepts for PrEP adherence in the PrEP revolution: from clinical trials to routine practice.Mitigating the Effects of Nonadherence in Clinical Trials.Successful Implementation of HIV Preexposure Prophylaxis: Lessons Learned From Three Clinical Settings.How Presentation of Drug Detection Results Changed Reports of Product Adherence in South Africa, Uganda and Zimbabwe.Social Desirability Bias and Prevalence of Sexual HIV Risk Behaviors Among People Who Use Drugs in Baltimore, Maryland: Implications for Identifying Individuals Prone to Underreporting Sexual Risk Behaviors.Comparison of self-report and electronic monitoring of 6MP intake in childhood ALL: a Children's Oncology Group study.A Patient-Centered Prescription Drug Label to Promote Appropriate Medication Use and Adherence.Comparing pharmacologic measures of tenofovir exposure in a U.S. pre-exposure prophylaxis randomized trial.
P2860
Q27300707-F5FAF42C-BCDF-45C4-A30D-D11C43DB5787Q28546083-0BE4F38E-C11D-4F54-AC2A-D3F0799A449CQ31034585-1366A22F-059B-4210-85AF-6811D3AC0667Q35473669-1635C512-A64E-4208-9CAD-7BBAC9C68CE8Q36337967-727C6627-0BC0-4AC4-9724-E8C68B827E13Q36406923-105895D0-C1BA-46F3-9FF8-36DBD5CFBA37Q36710299-D4986683-F3B7-4757-9626-03D717B02ACFQ37344145-B5C9E3A5-C37A-43D1-9AC0-E988EF888B1BQ38742749-23762372-4B46-477B-B177-6F836D0F7E23Q38767384-AC5E6A7F-D75C-4DE6-BF8C-F51F77A4FF58Q38783135-87C747CA-D01D-4414-87CB-69B101D8086FQ43892208-E95768AF-D43F-4697-A1E9-0F1B759A87F6Q44338827-6F2735C5-00D8-481B-8034-EC881B49219DQ47556636-BF50A4B0-BAB6-4630-BC3B-AB0737635795
P2860
Accuracy of Self-Report and Pill-Count Measures of Adherence in the FEM-PrEP Clinical Trial: Implications for Future HIV-Prevention Trials.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Accuracy of Self-Report and Pi ...... Future HIV-Prevention Trials.
@ast
Accuracy of Self-Report and Pi ...... Future HIV-Prevention Trials.
@en
type
label
Accuracy of Self-Report and Pi ...... Future HIV-Prevention Trials.
@ast
Accuracy of Self-Report and Pi ...... Future HIV-Prevention Trials.
@en
prefLabel
Accuracy of Self-Report and Pi ...... Future HIV-Prevention Trials.
@ast
Accuracy of Self-Report and Pi ...... Future HIV-Prevention Trials.
@en
P2093
P2860
P1433
P1476
Accuracy of Self-Report and Pi ...... Future HIV-Prevention Trials.
@en
P2093
Amy L Corneli
Angela D M Kashuba
Ansley Lemons
Caleb Parker
Douglas Taylor
Johan Lombaard
Julie Ambia
Lut Van Damme
Mookho Malahleha
P2860
P2888
P304
P356
10.1007/S10461-014-0859-Z
P50
P577
2015-05-01T00:00:00Z